Finanical Statements
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda (RMDA.CA) Reports 3 Months Consolidated Results
Published at 19 May 2026 at 10:59Related stock: RMDA
AI Summary
AI-powered disclosure summary — Coming soon 🔜
Company Name : Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
ISIN Code : EGS381B1C015
Currency : EGP
F/S Consolidated Period : From 01/01/2026 To 31/03/2026
Net Profit : 103,244,431
F/S Consolidated Period : From 01/01/2025 To 31/03/2025
Net Comparative Profit : 85,932,625
Audit Status : Reviewed
Source : Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
The Financial Statements in Arabic (939 KB)
The Financial Statements in English (543 KB)
ISIN Code : EGS381B1C015
Currency : EGP
F/S Consolidated Period : From 01/01/2026 To 31/03/2026
Net Profit : 103,244,431
F/S Consolidated Period : From 01/01/2025 To 31/03/2025
Net Comparative Profit : 85,932,625
Audit Status : Reviewed
Source : Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
The Financial Statements in Arabic (939 KB)
The Financial Statements in English (543 KB)